Residential Ventilation Systems and Filtration for Asthma Control in Adults

Not Applicable

Completed

• Conditions: Asthma; Pollution; Exposure
• Interventions: Device: Residential mechanical ventilation system (Exhaust); Device: Residential mechanical ventilation system (CFIS) and air filtration upgrades; Device: Residential mechanical ventilation system (ERV) and air filtration upgrades

• Registration Number: NCT06098287
• Lead Sponsor: Illinois Institute of Technology

Brief Summary

The goal of this study was to investigate the effectiveness of three common approaches to upgrading residential mechanical ventilation systems in existing homes for improving asthma-related health outcomes, reducing indoor pollutants of both indoor and outdoor origin, and maintaining adequate environmental conditions and ventilation rates in a cohort of adult asthmatics in existing homes in Chicago, IL.

Detailed Description

The Breathe Easy Study utilized a quasi-randomized, within-subjects, parallel-group, pre-post intervention study design with four weeklong periods of indoor air quality (IAQ) and indoor environmental data collection for approximately one year before the installation of mechanical ventilation systems, followed by four weeklong periods of IAQ and indoor environmental data collection for approximately one year after the installation of mechanical ventilation systems, conducted from July 2017 through March 2020 in Chicago, IL. With the nature of a healthy home intervention study by installing residential mechanical ventilation systems within the timeframe, each participant received interventions in the middle of the study period, including continuous exhaust-only systems; intermittent powered central-fan-integrated-supply (CFIS) systems; or continuous balanced systems with an energy recovery ventilator. Thus, each participant served as their own control and there was no formal control group that did not receive intervention nor did they receive a sham/placebo intervention. Primary health outcome, asthma control, was assessed by using the Asthma Control Test (ACT) every month, and quality of life, stress, and other asthma-related health outcomes were assessed via the baseline and end-line surveys.

Study Timeline

• Study Start: 2017-01-01
• Primary Completion: 2020-11-30
• Study Completion: 2020-11-30
• Status Verified: 2023-10
• Study First Submitted: 2023-10-14
• Study First Submitted QC: 2023-10-19
• Last Update Submitted: 2023-10-19
• Study First Posted: 2023-10-24
• Last Update Posted: 2023-10-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

• Age: 18 - 90+ years.
• English speaking and writing.
• Able to provide consent.
• Chicago resident.
• Households with at least one occupant with asthma
• Non-smoking houses
• Participant-owned houses
• Participant's agreement to surveys and IAQ monitoring over 2 years

Exclusion Criteria

• Houses outside Chicago, IL USA
• Houses with significant health and safety issues

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention (Exhaust-only ventilation)	Residential mechanical ventilation system (Exhaust)	A study group with a continuous exhaust-only ventilation system
Intervention (Central-fan-integrated-supply ventilation)	Residential mechanical ventilation system (CFIS) and air filtration upgrades	A study group with an intermittent central-fan-integrated-supply ventilation system and air filtration upgrades
Intervention (Balanced energy recovery ventilation)	Residential mechanical ventilation system (ERV) and air filtration upgrades	A study group with a continuous balanced energy recovery ventilation system and air filtration upgrades

Primary Outcome Measures

Name	Time	Method
Asthma Control	Each month throughout the study completion, an average of 2 years (24 months)	Asthma Control Test (ACT) is a 5-item clinically validated survey, which is designed to measure the multi-dimensional nature of asthma control, including asthma symptoms, utilization of rescue medications, and the impact of asthma on daily functioning. The ACT score ranges from 5 ("poor control of asthma") to 25 ("complete control of asthma")

Secondary Outcome Measures

Name	Time	Method
Comorbidities	Baseline (July 2017) and end-line (March 2020, end of study completion)	Comorbidities via survey
Health-Related Quality of Life	Baseline (July 2017) and end-line (March 2020, end of study completion)	12-Item Short Form Survey (SF-12) measures eight concepts commonly represented in widely used surveys: general health, physical functioning, bodily pain, vitality (energy/fatigue), social functioning, role limitations due to physical and emotional problems, and mental health (psychological distress and psychological well-being). Both the SF-12 physical (PCS) and mental (MCS) component summary scales use norm-based scoring, 0-100, with higher scores indicating better physical and mental health functioning.
Stress	Baseline (July 2017) and end-line (March 2020, end of study completion)	Perceived Stress Scale (PSS) is a 10-item psychological assessment to understand how unpredictable, uncontrollable, and overloaded participants find their lives. The PSS score ranges from 0 to 40 with higher scores indicating higher perceived stress, and scores ranging from 0 to 13, from 14 to 26, and from 27 to 40 are considered low, moderate, and high perceived stress, respectively.
Asthma medications	Baseline (July 2017) and end-line (March 2020, end of study completion)	Asthma medications via survey

Trial Locations

Locations (1)

Illinois Institute of Technology; 🇺🇸 Chicago, Illinois, United States